Introduction: American cutaneous leishmaniasis (ACL) is a noncontagious disease, a chronic disease that affects the skin and cartilaginous structures of the nasopharynx localized or diffuse. Treatment of ACL is a challenge because the available drugs have high toxicity (nephrotoxicity, hepatotoxicity, and cardiotoxicity) and none of them are quite effective.